Ebola virus disease: A narrative review

Area of Science:

• * Virology and infectious diseases, focusing on the Ebola virus.
• * Epidemiology and public health concerning Ebola virus disease outbreaks.

Background:

• * Ebola virus disease (EVD), or Ebola hemorrhagic fever, is a highly contagious and often fatal illness caused by the Ebola virus.
• * First identified in 1976, EVD has caused intermittent outbreaks in several African nations, primarily spreading through direct contact with infected bodily fluids.
• * The 2014-2016 West Africa outbreak highlighted the critical need for robust control and prevention strategies.

Purpose of the Study:

• * To provide a comprehensive overview of Ebola virus disease.
• * To detail the history, transmission routes, clinical symptoms, and diagnostic approaches for EVD.
• * To review current treatment modalities, epidemiological patterns, and ongoing research into novel therapies and vaccines.

Main Methods:

• * Literature review and synthesis of existing data on Ebola virus disease.
• * Analysis of historical outbreak information and epidemiological trends.
• * Examination of current and experimental treatment strategies, including supportive care, therapeutics, and vaccines.

Main Results:

• * EVD is characterized by symptoms like fever, fatigue, muscle pain, headache, and hemorrhage.
• * Supportive care, including fluid and electrolyte replacement and secondary infection management, remains the cornerstone of EVD treatment.
• * Experimental therapies (monoclonal antibodies, antivirals) and vaccines show promise but require further study for efficacy and long-term safety.

Conclusions:

• * Early detection and aggressive supportive care significantly improve survival outcomes for Ebola virus disease.
• * Ongoing research is crucial for developing more effective treatments and preventative vaccines against the Ebola virus.
• * Continued vigilance and public health interventions are necessary to manage and control EVD outbreaks.